SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006590
Filing Date
2021-05-10
Accepted
2021-05-10 08:53:04
Documents
54
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20210331x10q.htm   iXBRL 10-Q 1508139
2 EX-10.1 qure-20210331xex10d1.htm EX-10.1 96621
3 EX-31.1 qure-20210331xex31d1.htm EX-31.1 14574
4 EX-31.2 qure-20210331xex31d2.htm EX-31.2 14570
5 EX-32.1 qure-20210331xex32d1.htm EX-32.1 8889
  Complete submission text file 0001558370-21-006590.txt   5684296

Data Files

Seq Description Document Type Size
6 EX-101.SCH qure-20210331.xsd EX-101.SCH 38299
7 EX-101.CAL qure-20210331_cal.xml EX-101.CAL 41821
8 EX-101.DEF qure-20210331_def.xml EX-101.DEF 195133
9 EX-101.LAB qure-20210331_lab.xml EX-101.LAB 413785
10 EX-101.PRE qure-20210331_pre.xml EX-101.PRE 317264
11 EXTRACTED XBRL INSTANCE DOCUMENT qure-20210331x10q_htm.xml XML 785804
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 21905414
SIC: 2834 Pharmaceutical Preparations